Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Alcaftadine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 82,195Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic`s Generics Alcaftadine Receives Approval in US
    Alembic`s Generics Alcaftadine Receives Approval in US

    02 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209290

    FDA
    02 Oct 2024
    Share Share
    A Novel Method of Manufacturing Alcaftadine
    A Novel Method of Manufacturing Alcaftadine

    29 Jun 2022

    // Saharsh Davuluri PRESS RELEASE

    https://www.neulandlabs.com/blog/2022/06/29/a-novel-method-of-manufacturing-alcaftadine/

    Saharsh Davuluri PRESS RELEASE
    29 Jun 2022
    Share Share
    Alembic Pharma share price up over 3% after USFDA tentatively approves
    Alembic Pharma share price up over 3% after USFDA tentatively approves

    20 Apr 2020

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/stocks/alembic-pharma-share-price-up-over-3-after-usfda-tentatively-approves-conjunctivitis-related-drug-5165891.html

    MONEYCONTROL
    20 Apr 2020
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    21 Jun 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    List of New Paragraph IV Certifications as of Aug 21, 2018
    List of New Paragraph IV Certifications as of Aug 21, 2018

    21 Aug 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf

    FDA
    21 Aug 2018
    Share Share